Detalhe da pesquisa
1.
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
JAMA Oncol
; 9(6): 841-846, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103916
2.
Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
J Allergy Clin Immunol Pract
; 4(2): 338-40, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26725157